Trial Profile
A first-in-human clinical study to assess safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of RO7020531 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 May 2018
Price :
$35
*
At a glance
- Drugs RO 7020531 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Biomarker; First in man; Pharmacodynamics; Pharmacokinetics
- 17 May 2018 New trial record
- 14 Apr 2018 Results presented at The International Liver Congress 2018